510(k) Report

510(k) · Cleared

Cleared

HemoScreen Hematology Analyzer

K180020510(k) TraditionalCleared Oct 29, 2018300-day reviewClass II21 CFR 864.5220

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Pixcell Medical Technologies, Ltd. · GKZ Counter, Differential Cell

Cleared on Oct 29, 2018 as substantially equivalent to K112605 (Sysmex America, Inc., 2012) after a 300-day review. Its family tree reaches back 3 generations to 2004. 2 later devices descend from it.

Decided
Oct 29, 2018
Review
300 days
Class
Class II
Product code
GKZ
Recalls
None
Predicates
1

Its longest line of descent runs back 3 generations to K040073 (2004). 2 later devices descend from it, 1 citing it directly.

  1. Root · 3 generations backK040073 Sysmex Automated Hematology Analyzer, XE-2100 Series (XE-2100…Sysmex America, Inc. · 2004
  2. 2 generations backK071967 Sysmex XE-5000Sysmex America, Inc. · 2007 · Recalled
  3. 1 generation backK112605 Sysmex XN-SeriesSysmex America, Inc. · 2012 · Recalled
  4. This deviceK180020 HemoScreen Hematology AnalyzerPixcell Medical Technologies, Ltd. · 2018
  5. Descendant · cites it directly · 1 of its ownK222148 HemoScreen Hematology AnalyzerPixcell Medical Technologies, Ltd. · 2023
  6. Descendant · 2 generations on · 0 of its ownK240636 HemoScreen Hematology AnalyzerPixcell Medical Technologies · 2024

Most influential descendants

Showing 2 of 2 · See all
  • K222148HemoScreen Hematology AnalyzerPixcell Medical Technologies, Ltd. · 2023 · cites it directly1descendant
  • K240636HemoScreen Hematology AnalyzerPixcell Medical Technologies · 2024 · 2 generations on0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−3K040073Sysmex Automated Hematology Analyzer, XE-2100 Series (XE-2100, XE-2100L)Sysmex America, Inc.2004—
−2K071967Sysmex XE-5000Sysmex America, Inc.20071
−1K112605Sysmex XN-SeriesSysmex America, Inc.20122
0 (this device)K180020HemoScreen Hematology AnalyzerPixcell Medical Technologies, Ltd.2018—
+1K222148HemoScreen Hematology AnalyzerPixcell Medical Technologies, Ltd.2023—
+2K240636HemoScreen Hematology AnalyzerPixcell Medical Technologies2024—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
202310
202410
FIG. 1 — Lineage of K180020, 2004–2024Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in GKZ? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new GKZ device

  1. #1 K250943 Sysmex XR-Series (XR-10) Automated Hematology…score 13.2 · 3 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K112605Sysmex XN-Series
Summary page 4
…ication: 21 CFR 864.5220 807.92 (a)(3): Identification of the legally marketed predicate devices Sysmex XN Series (Sysmex America, Inc, Lincolnshire, IL), cleared under K112605 807.92 (a)(4): Device Description HemoScreen is a point of care (POC), automated hematology analyzer that provides 20 common CBC…
Sysmex America, Inc.20122

Also cleared against K112605: 12 other devices →

What descends from it? (2)

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K222148HemoScreen Hematology AnalyzerPixcell Medical Technologies, Ltd.20231

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 14 years and passes through 2 companies; a new generation was cleared every 4.9 years on median.
  • 2 of the 3 ancestors have a recall of any class.
  • Of its descendants, K222148 (Pixcell Medical Technologies, Ltd., 2023) has gone furthest, with 1 descendant of its own.
  • 12 other devices also cite its predicate K112605.

How does its category compare?

All GKZ devices

GKZ Counter, Differential Cell: FDA decisions, review times, recalls and adverse event reports over 20 years. 2018, this device’s year, is highlighted.

FDA decisions per year · GKZ

4in 2025

2007: 62008: 62009: 62010: 42011: 32012: 32013: 12014: 32015: 32016: 32017: 42018: 32019: 52020: 12022: 32023: 42024: 32025: 42026 (partial year): 4
2007high 6 (2007) · low 0 (2021)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · GKZ

108in 2025

2007: 117 days median2008: 99 days median2009: 147 days median2010: 290 days median2011: 315 days median2012: 408 days median2014: 165 days median2015: 273 days median2016: 198 days median2017: 280 days median2018: 270 days median2019: 210 days median2022: 638 days median2023: 329 days median2024: 157 days median2025: 108 days median2026 (partial year): 254 days median
2007high 638 (2022) · low 99 (2008)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · GKZ

1in 2025

2007: 372008: 52009: 132010: 272011: 282012: 72013: 62015: 32016: 32017: 32018: 2, 2 Class I2019: 22020: 12022: 42023: 12025: 1
2007high 37 (2007) · low 0 (2014)2026

Class I (2 since 2007) Class II/III not classified

Adverse event reports per year · GKZ

77in 2025

2007: 2682008: 9252009: 5592010: 8962011: 2,9052012: 2,9592013: 3,0702014: 3,1122015: 1,9722016: 3,3382017: 2292018: 4972019: 9082020: 3422021: 3912022: 1982023: 1552024: 1152025: 77
2007high 3,338 (2016) · low 77 (2025)2025

MAUDE reports naming product code GKZ, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
2007611737268
20086995925
2009614713559
2010429027896
20113315282,905
2012340872,959
20131—63,070
2014316503,112
2015327331,972
2016319833,338
201742803229
201832702 (2)497
201952102908
20201—1342
20210—0391
202236384198
202343291155
202431570115
20254108177
202642540—

What is it indicated for?

The HemoScreen is a point-of-care (POC) automated hematology analyzer intended for the enumeration and classification of the following parameters in capillary and venous whole blood (K2EDTA anticoagulated): WBC, RBC, HGB, HCT, MCV, MCH, MCHC, RDW, PLT, MPV, NEUT%, NEUT#, LYMP%, LYMP#, MONO%, MONO#, EO%, EO#, BASO %, and BASO#. The HemoScreen is for in vitro diagnostic use in clinical laboratories and/or POC settings for adults and children at least 2 years of age.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K180020: HemoScreen Hematology Analyzer.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K180020

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026